Demant

Demant is a Danish international group focused on hearing healthcare, hearing aids, audiological diagnostics, hearing-care retail and selected communications products. Its origins date to 1904, when Hans Demant obtained a hearing aid for his hearing-impaired wife and began selling devices in Odense. The business later developed under the Oticon name and became one of Denmark’s best-known hearing technology enterprises. The company’s activities extend across much of the hearing-care value chain. Its hearing-aid portfolio has included Oticon, Bernafon, Sonic and Philips-branded hearing solutions. Its retail operations include networks such as Audika, HearingLife, Hidden Hearing and other country-specific businesses. The group also supplies audiometers, tympanometers, diagnostic systems and related equipment through brands including Interacoustics, Maico Diagnostics, Amplivox, Grason-Stadler, MedRx, AudioScan and Inventis. Demant’s corporate history is closely connected with Oticon. During the First and Second World War periods, the company expanded its distribution and began assembling and manufacturing hearing devices in Denmark when imports became difficult. Oticon became the company’s official name in 1943 and subsequently developed an international export and subsidiary network. In 1957, the founding family transferred its shares to a charitable foundation, now known as the William Demant Foundation, whose purposes include supporting people with hearing impairment. The group broadened substantially from the 1980s onward. Oticon Holding A/S was established in 1983, and under Lars Kolind the company became known for an unconventional project-based management model sometimes called the “spaghetti organisation.” International expansion and acquisitions added hearing-aid, diagnostics and retail capabilities. The purchase of Bernafon and Maico helped establish a broader technology platform, while later acquisitions such as Interacoustics, Amplivox and Grason-Stadler strengthened diagnostics. William Demant Holding was listed in Copenhagen in 1995 and adopted that corporate name in 1997 to distinguish the group from the Oticon operating brand. Niels Jacobsen became president and chief executive in 1998 and led the group for many years. In the 2000s and 2010s, Demant expanded into office and gaming headsets through its Sennheiser joint venture, later operating the business under the EPOS brand. It also entered hearing implants through Neurelec and Oticon Medical, while expanding hearing-care retail through the acquisition of a majority stake in Audika. The group changed its name from William Demant Holding to Demant in 2019. This reflected a group-wide brand strategy intended to make cooperation across the businesses more visible while retaining established customer-facing brands. Demant later agreed to sell Oticon Medical’s cochlear-implant business to Cochlear; the transaction closed in 2024, marking a retreat from cochlear implants while other hearing-care and technology activities remained in the group. In 2024, Demant also announced that it was seeking a more suitable owner for EPOS. The group continued its retail expansion in China through the acquisition of ShengWang and its clinic network, and in 2025 announced the acquisition of Germany’s KIND Group. Today, Demant is best understood as a multi-brand hearing healthcare group rather than a single consumer-product label. Its principal businesses combine hearing instruments, professional diagnostics, retail audiology and related communications technology. The William Demant Foundation remains a significant long-term shareholder and philanthropic institution associated with the company.

Demant traces its beginnings to 1904, when Hans Demant purchased a hearing aid for his wife and entered the hearing-aid trade in Odense, Denmark. He secured a relationship with the American General Acousticon Company and began selling Acousticon devices. After his death in 1910, his widow Camilla and son William Demant continued the business. William expanded distribution into Finland and Russia and later travelled to Russia with his wife, Ida Emilie Høst, to develop sales. The company moved from distribution toward local assembly and production. William obtained a licence to produce hearing aids and introduced the Acousticus trademark. During the Second World War, imports from the United States, Britain and France became difficult, encouraging the company to manufacture components and assemble devices in Denmark. Oticon became the official company name in 1943. After the war, Danish hearing-aid manufacturing grew rapidly and Oticon developed an export business, including cooperation with American manufacturer Charles Lehman through the American-Danish Oticon Corporation. A major ownership transition occurred in 1957, when William Demant and Ida Emilie Høst donated the family’s shares to the William Demant and Ida Emilie Foundation, later known as the Oticon Foundation and now the William Demant Foundation. The foundation’s charitable mission has a particular emphasis on people with hearing impairment. During the 1960s, Oticon established subsidiaries and production or research activities in several European countries, the United States and other international markets. Eriksholm became an important research centre, and Oticon grew into a leading hearing-aid supplier. Oticon Holding A/S was formed in 1983. During Lars Kolind’s leadership, the company introduced a highly decentralised project structure and promoted the idea of challenging conventional assumptions. This organisational experiment became associated with the term “spaghetti organisation.” The group also continued international expansion and acquired Bernafon, a Swiss hearing-aid manufacturer, together with Maico, a diagnostics-equipment business. These moves helped create a group with both hearing instruments and professional diagnostic products. The company was listed on the Copenhagen Stock Exchange in 1995. In 1997, Oticon Holding A/S changed its name to William Demant Holding A/S so that the corporate group would not be confused with the Oticon operating brand. Niels Jacobsen became president and chief executive in 1998. During the following decade, the group acquired Interacoustics and later Amplivox and Grason-Stadler, building a major diagnostics platform. In 2003, it formed a joint venture with Sennheiser electronic for office and gaming headsets. The group moved its headquarters to Smørum in 2005. In the 2010s, William Demant Holding expanded into additional hearing-aid brands, retail, hearing implants and communications. The acquisition of Sonic added another hearing-aid brand, while Neurelec brought cochlear implants into the group and was subsequently rebranded as Oticon Medical. A majority stake in French hearing-care retailer Audika broadened the retail business. In 2017, Niels Jacobsen announced his departure as group CEO and Søren Nielsen succeeded him. In 2018, Demant and Sennheiser ended their headset joint venture; the communications and gaming activities continued under the fully owned EPOS brand. A partnership with Philips also added Philips-branded hearing solutions to the group’s market offering. In 2019, William Demant Holding adopted the name Demant A/S and launched a group brand strategy intended to improve cooperation across its businesses. In 2022, Demant agreed to sell Oticon Medical to Cochlear, and the transaction closed in 2024. The company thereby exited the cochlear-implant business while retaining its central hearing-aid, diagnostics and hearing-care operations. Demant also announced a search for a new owner for EPOS and acquired ShengWang’s Chinese clinic network. In 2025, the group announced the acquisition of Germany’s KIND Group. Demant therefore remains a diversified hearing healthcare company built around technology brands, diagnostic equipment and international hearing-care services.

1. 2025KIND Group acquisition announced

   Demant announces the acquisition of Germany’s KIND Group.

   Source
2. 2024Oticon Medical divestment closes

   The sale of the cochlear-implant business to Cochlear is completed.

   Source
3. 2024ShengWang acquisition expands Chinese retail

   Demant acquires ShengWang and its network of hearing-aid clinics in China.

   Source
4. 2022Agreement to sell Oticon Medical

   Demant agrees to sell Oticon Medical to Cochlear and announces its intention to leave the cochlear-implant business.

   Source
5. 2019The group adopts the Demant name

   William Demant Holding A/S changes its name to Demant A/S and introduces a new group brand strategy.

   Source
6. 2018EPOS becomes a fully owned business

   The Sennheiser joint venture ends, and the enterprise and gaming audio activities continue under the EPOS brand.

   Source
7. 2018Philips hearing solutions partnership

   Demant and Philips announce a partnership to bring Philips-branded hearing solutions to market.

   Source
8. 2017Søren Nielsen becomes chief executive

   Søren Nielsen succeeds Niels Jacobsen as president and CEO, while Jacobsen moves to William Demant Invest.

   Source
9. 2015Audika becomes part of the retail expansion

   Demant takes a majority stake in French hearing-care retailer Audika.

   Source
10. 2013Neurelec acquisition expands hearing implants

    Demant acquires French company Neurelec and adds cochlear-implant capabilities.

    Source
11. 2010Sonic is acquired

    Otix Global is acquired, adding Sonic as another hearing-aid brand in the group.

    Source
12. 2009Grason-Stadler joins the diagnostics business

    The acquisition of Grason-Stadler expands Demant’s range of professional diagnostic instruments.

    Source
13. 2008Amplivox joins the diagnostics portfolio

    The acquisition of Amplivox strengthens Demant’s audiological diagnostics business.

    Source
14. 2003Headset joint venture with Sennheiser

    William Demant Holding and Sennheiser establish a joint venture for office and gaming headsets.

    Source
15. 1998Niels Jacobsen becomes group chief executive

    Niels Jacobsen is appointed president and chief executive of William Demant Holding.

    Source
16. 1997Corporate name changes to William Demant Holding

    The holding company changes its name to distinguish the corporate group from the Oticon brand.

    Source
17. 1995William Demant Holding is listed

    The company is listed on the Copenhagen Stock Exchange.

    Source
18. 1991Oticon introduces its project-based organisational model

    Under Lars Kolind, Oticon adopts a decentralised structure built around self-organised project teams, later associated with the “spaghetti organisation.”

    Source
19. 1983Oticon Holding A/S is established

    The corporate holding structure is formalised as Oticon Holding A/S.

    Source
20. 1957Founding-family shares transferred to a foundation

    William Demant and Ida Emilie Høst transfer the family’s shares to a charitable foundation focused in part on hearing impairment.

    Source
21. 1943Oticon becomes the official company name

    The company adopts Oticon as its official name during the period when wartime import restrictions encourage local manufacturing.

    Source
22. 1915Licensed production and the Acousticus trademark

    William Demant expands sales into Russia and begins licensed production and Danish assembly of hearing aids under the Acousticus name.

    Source
23. 1910The Demant family continues the company

    After Hans Demant’s death, Camilla Demant and William Demant take responsibility for the business.

    Source
24. 1904Hans Demant enters the hearing-aid business

    Hans Demant obtains a hearing aid for his wife and begins selling hearing devices in Odense, Denmark.

    Source

An integrated hearing healthcare and audio technology group spanning hearing instruments, audiological diagnostics, hearing-care retail and communications solutions.

• OticonHearing aids1943

  Oticon is Demant’s principal hearing-aid brand and the brand most directly connected with the group’s historical origins. Its portfolio covers hearing instruments and associated solutions designed for clinical fitting and everyday hearing support. Oticon also operated the group’s hearing-implant business before the cochlear-implant activities were divested to Cochlear.

• BernafonHearing aids

  Bernafon is a Swiss-origin hearing-aid brand acquired by Demant during the group’s international expansion. It provides hearing instruments and related fitting solutions through professional hearing-care channels and complements Demant’s other hearing-aid brands.

• Philips Hearing SolutionsHearing aids2018

  Philips Hearing Solutions is a hearing-aid offering brought to market through the partnership between Demant and Philips announced in 2018. It extends Demant’s multi-brand approach by combining Demant’s hearing technology and distribution capabilities with Philips branding.

• SonicHearing aids2010

  Sonic became part of Demant through the acquisition of Otix Global. The brand added another hearing-aid platform to the group and supported Demant’s strategy of serving different market segments with distinct branded propositions.

• InteracousticsAudiological diagnostics

  Interacoustics is a Demant diagnostics business supplying professional audiological equipment. Its activities include systems used by hearing professionals and clinics for assessment, measurement and diagnostic workflows.

• Maico DiagnosticsAudiological diagnostics

  Maico provides diagnostic equipment for hearing and balance assessment. It entered the Demant group through the acquisition of Bernafon and contributed to the development of Demant’s professional diagnostics business.

• EPOSCommunications and gaming audio2018

  EPOS is Demant’s communications technology brand for enterprise headsets, meeting-room systems and gaming audio. It developed from the former Sennheiser joint venture and became a wholly owned Demant business after the partners ended their collaboration in 2018. In 2024, Demant said it was seeking a more suitable owner for the business.

• AudikaHearing-care retail

  Audika is an international hearing-care retail network that became part of Demant through a majority investment in 2015. It provides hearing assessments, hearing-aid fitting, aftercare and related services through clinics in multiple markets.

• HearingLifeHearing-care retail

  HearingLife is one of Demant’s hearing-care retail businesses, operating clinic networks in markets including the United States and Canada. Its services generally combine hearing testing, counselling, device selection, fitting and ongoing support.

• Oticon MedicalHearing implants2014

  Oticon Medical was Demant’s hearing-implant business, created after the acquisition and rebranding of Neurelec. It included cochlear-implant activities and later developed the Neuro cochlear implant. Demant agreed to sell the business to Cochlear in 2022, with the divestment completed in 2024.

• 2025Announce acquisition of KIND GroupM&A

  Demant continued expanding its hearing-care retail platform in Europe.

  What changed. Demant announced the acquisition of Germany’s KIND Group.

  Aftermath. The announced transaction was expected to broaden Demant’s German hearing-care presence; completion details are not provided in the supplied material.

  Announced acquisition consideration. EUR 700 million (2025 announcement)

  Source
• 2024Acquire ShengWang in ChinaM&A

  Demant sought to expand its hearing-care retail presence in the Chinese market.

  What changed. Demant acquired ShengWang and its network of approximately 500 hearing-aid clinics.

  Aftermath. The acquisition strengthened Demant’s direct clinic and hearing-care distribution platform in China.

  Reported acquisition consideration. CNY 1.75 billion (2024 announcement)

  Source
• 2024Review ownership options for EPOSStrategy

  Demant indicated that EPOS might have a more suitable owner outside the group as it reviewed the strategic fit of the communications and gaming business.

  What changed. The group announced its intention to seek a new owner for EPOS.

  Aftermath. No completed divestment is identified in the supplied reference material.

  Source
• 2022Sell Oticon Medical to CochlearM&A

  Demant decided to leave the cochlear-implant business and concentrate on its principal hearing-aid, diagnostics and hearing-care activities.

  What changed. Demant agreed to sell Oticon Medical to Cochlear Limited.

  Aftermath. The transaction closed in 2024 and removed the cochlear-implant business from Demant’s portfolio.

  Announced transaction consideration. DKK 850 million (2022 announcement)

  Source
• 2019Adopt the Demant corporate identityStrategy

  The group sought a common identity that could support collaboration across a portfolio of established brands.

  What changed. William Demant Holding A/S changed its name to Demant A/S and launched a new group brand strategy.

  Aftermath. Demant became the group-level identity while brands such as Oticon, Bernafon, Audika and EPOS retained their market-facing roles.

  Source
• 2018End the Sennheiser headset joint ventureStrategy

  Demant and Sennheiser decided to end their joint venture covering office and gaming headsets.

  What changed. The enterprise and gaming activities continued as independent divisions under Demant’s EPOS brand.

  Aftermath. EPOS became a wholly owned Demant business focused on enterprise communications and gaming audio.

  Source
• 1997Separate the corporate-group name from the Oticon brandStrategy

  The company considered it disadvantageous for the holding group and one of its operating businesses to use the same name.

  What changed. Oticon Holding A/S was renamed William Demant Holding A/S.

  Aftermath. The change clarified the distinction between the corporate group and the Oticon hearing-aid brand.

  Source

• 2025Demant announces acquisition of KIND Group

  Demant announced an agreement to acquire Germany’s KIND Group, expanding its hearing-care retail and services footprint.

  M&A
  Source
• 2025Demant acquires KIND Group

  Demant acquired Germany’s KIND Group in a transaction reported at approximately EUR 700 million, expanding its European hearing-care and retail presence.

  M&A
  Source
• 2024Sale of Oticon Medical hearing-implant business closes

  The divestment of the cochlear-implant business to Cochlear was completed, reducing Demant’s exposure to hearing implants.

  M&A
  Source
• 2024Demant acquires ShengWang and its Chinese clinic network

  Demant acquired ShengWang and a network of approximately 500 hearing-aid clinics in China, strengthening its direct hearing-care presence in the market.

  M&A
  Source
• 2024Demant seeks a new owner for EPOS

  The group announced that it was looking for a more suitable owner for EPOS, its enterprise communications and gaming audio business.

  M&A
  Source
• 2024Sale of Oticon Medical cochlear-implant business completed

  The previously announced divestment closed, moving Demant out of the cochlear-implant business while related bone-anchored activities were treated separately.

  M&A
  Source
• 2024Demant acquires ShengWang and Chinese clinic network

  Demant acquired ShengWang and its network of approximately 500 hearing-aid clinics in China for a reported CNY 1.75 billion.

  M&A
  Source
• 2022Demant agrees to sell Oticon Medical to Cochlear

  Demant announced an agreement to sell Oticon Medical’s hearing-implant business to Australian implant company Cochlear and to exit the cochlear-implant segment.

  M&A
  Source
• 2019William Demant Holding changes its name to Demant

  The corporate group adopted the shorter Demant name as part of a new group-wide brand strategy.

  Other
  Source

1. Demant